Integrated and holistic healthcare clinic London


Turmeric and its amazing healing power

First, I want to clarify some concepts: Curry is a mixture of spices, usually cardamom, cayenne pepper, cinnamon, cloves, coriander seeds, cumin, fennel seeds, fenugreek, nutmeg, red and black pepper, poppy and sesame seeds, saffron and large amounts of turmeric (20-30%). Turmeric powder is obtained by grinding the dried rhizome of the Curcuma longa plant. It was already one of the 250 medicinal plants mentioned in a series of medicinal treatises dating from approximately 3.000 BC. Curcuminoids are the main compounds in turmeric (around 5% of the weight of the dried root) and are not only responsible for turmeric’s bright yellowish colour, but also of the beneficial effects, being the main component called curcumin. [1-3] Curcumin has shown to have a large list of beneficial actions:

  • It is a potent anti-inflammatory and therefore helpful in any inflammatory conditions.[4,5,43]
  • It helps preventing not only cardiovascular disease but also Parkinson’s and Alzheimer’s disease.[6-8]
  • Is has also shown to ease digestive disorders, including inflammatory bowel diseases.[9]

       Including the following anti-cancer properties (Curcumin is known as the most powerful anticancer substance [10,11,44,45]):

  • Its anti-inflammatory quality reduces pain produced by cancer, both primary tumours and metastasis similar to mistletoe.
  • Stops progression of metastasis [12]
  • Induces apoptosis (cancer cell suicide) [13]
  • Its anti-oxidant effect prevents free radicals to damage our DNA [14,15]
  • It stimulates our immune system [16]
  • It inhibits the NF-kappa B factor (a factor that protects the tumour from our immune system) [17]
  • It not only enhances the effect of the chemotherapy, but also protects our mucus membranes, liver and kidneys from its toxic effects [18-21]
  • It enhances the effect of the radiotherapy [22]

In addition, curcumin has shown to have a similar effect to some of the drugs designed to fight cancer: Remicade, Humira, Enbrel (inhibitors of the production of tumor necrosis factor), Avastin (inhibits production of vascular endothelial growth factor) and Herceptin (blocks Her2 receptors).[23]

Due to its notorious effects, currently, more than 20 clinical trials are underway to measure the effectiveness of turmeric and curcumin treating various cancers (colon, breast, pancreas and melanoma). Preliminary effects are very encouraging as they do not have side effects (or very few).

In one study carried out on patients with pancreas cancer in the terminal phase, administering curcumin led to a dramatic reduction in tumour size (73%) in a patient and stabilised the disease. [24-26]In other studies, curcumin as shown to inhibit the growth of all cancers (ovary, breast, uterus, liver, bile ducts, lung, pancreas, prostate, stomach, leukaemia, neck , melanoma, osteosarcoma, etc) [27- 42] and that it helps preventing and treating cancer, including metastasis [46-48] 

How to take it: Ideally, you should have at least 5g (1 tea spoon) every day. Be aware that turmeric delivered in capsules is very poorly absorbed by the digestive system [24]. In fact, if it’s not mixed with oil (ideally olive or linseed due to their own beneficial properties) and pepper or ginger, it does not pass the intestinal barrier.

Pepper multiplies the body’s absorption of turmeric by two thousand, as it contains a substance called pipperine which helps the curcumin to be absorbed [49-50].

You can prepare yourself a curcumin-drink: boil 200ml of water, dissolve 1 teaspoon of turmeric, add black pepper and some olive oil, let it cool down and drink it within 4 hours. Human trials have shown that curcumin can be used in doses up to 8g daily for up to 18 months without toxicity. [51]

Caution: if you are taking anticoagulants (blood- thinners) as turmeric can interfere increasing their effect. The easiest and most efficient way, however, is having it in its original form, as curry and adding it to your food. Its combination of various spices has shown to work together and having a great cytotoxic effect on cancer cells.

One study showed that after exposing oesophagus cancer cells to the extracts of curry, 88% of the cancer cells diet after 24hours! [52]T his may explain the much lower cancer rates in India, when compared with USA, despite the Indian’s exposure to numerous carcinogens in their environment, often on a worse scale that in the West. [53]  

 Integrated therapies for Cancer

The Integrated and Holistic Medicine now offers the Mistletoe therapy and IV drip therapy as cancer complementary treatments.

The IV drip therapy is available at our London clinic or you can have your your iv drip at your home.


  1. Prof. Richard Béliveau and Dr Denis Gingras, 2017 “Foods to fight cancer”. ISBN-13: 978-1465456281
  2. Fernández Martínez, Odile; 2013. Mis recetas anticáncer – Alimentación y vida anticancer. ISBN 978-84-7953-437-0
  3. Dr David Servan-Schreiber, 2007. “Anti cancer – a new way of life”. ISBN 978-0-718-15684-8
  4. Belcaro G, et al. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev. 2010 Dec; 15(4):337-44.
  5. Guimaraes MR, et a1. Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo. J Periodontal Res. 2011 Apr; 46(2):269-79.
  6. Miriyala S, Panchatcharam M, Rengarajulu P. Cardioprotective effects of curcumin. Adv Exp Med Biol. 2007;595:359-77.
  7. Mythri RB, et al. Glutamoyl diester of the dietary polyphenol curcumin offers improved protection againstperoxynitn’te-mediated nitrosative stress and damage of brain mitochondria in vitro: implications for Parkinson’s disease. Mol Cell Biochem. 2011Jan; 347(1—2):135-43.
  8. Belkacemi A, Doggui S, Dao L, Ramassamy C. Challenges associated with curcumin therapy in Alzheimer disease. Expert Rev M01 Med. 2011 Nov 4;13:e34.
  9. Rajasekaran SA. Therapeutic potential of curcumin in gastrointestinal diseases. World J Gastrointest Pathophysiol. 2011 Feb 15;2(1):1-14.
  10. Shehzad A, Wahid F, Lee YS. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim). 2010 Sep;343(9):489-99.
  11. Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of Curcumin, a Component of the Golden Spice, and Its Miraculous Biological Activities. Clin Exp Pharmacol Physiol. 2012 Mar;39(3):283-99.
  12. Kim SR, et al. Curcumin down-regulates Visfatin expression and inhibits breast cancer cell invasion.Endocrinology. 2012 Feb; 153(2):554-63.
  13. Malek SN, et al. Phytochemical and cytotoxic investigations of curcuma mangga rhizomes. Molecules. 2011 May 31;16(6):4539-48.
  14. Quiroga A, et al. Anti-breast cancer activity of curcumin on the human oxidation resistant cells ZR-75-1 with gamma-glutamyltranspeptidase inhibition. J Exp The Oncol. 2010;8(3):261-6.
  15. Griesser M, et al. Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin. J Biol Chem. 2011 Jan 14; 286(2): 1 1 14-24.
  16. Yue GG, et al. Evaluation of in vitro anti-proliferative and immunomodulatory activities of compounds isolated from Curcuma longa. Food Chem Toxicol. 2010 Aug-Sep; 48(8-9):2011-20.
  17. Olivera A, et al. Inhibition of the NF-KB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): Anti-inflammatory and anti-cancer properties. Intlmmunopharmacol. 2012 Feb;12(2):368- 77.
  18. Tsai MS, et al. Synergistic effect of curcumin and cisplatin via downregulation of thymidine phosphorylase and excision repair cross-complementary 1 (ERCC1). Mol Pharmacol. 2011 jul; 80(1): 136-46.
  19. Chatteriee SJ, Pandey S. Chemo-resistant melanoma sensitized by tamoxifen to low dose curcumin treatment through induction of apoptosis and autophagy. Cancer Biol Ther. 2011 Jan 15;11(2):216-28.
  20. Ganta S, Devalapally H, Amiji M. Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation. J Pharm Sci. 2010 Nov;99(11):4630-41.
  21. Goel A, Aggarwal BB. Curcumin. The golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer 2010; 62(7): 919-30.
  22. Yallapu M M, et al. Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res. 2010 Apr 29,311.
  23. Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007;595:1-75.
  24. Cheng, AL. et al. “Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions”, Anticancer Res 2001 ; 21 : 2895- 2900.
  25. Sharma, RA. et al. “Phase l clinical trial of oral curcumin: biomarkers of systemic activity and compliance”, Clin Cancer Res 2004; 10: 6847-6854.
  26. Dhillon, N. et al. “Phase II trial of curcumin in patients with advanced pancreatic cancer”, Clin Cancer Res 2008; 14:4491-9.
  27. Zhang X, et al. A novel mono-carbonyl analogue of curcumin induces apoptosis in ovarian carcinoma cells via endoplasmic reticulum stress and reactive oxygen species production. Mol Med Report. 2012 Mar; 5(3):739-44.
  28. Bayet-Robert M, al. Phase 1 dose escalation trial of docetaxel plus curcumin in patient with advanced and metastatic breast cancer. Cancer Biol Ther. 2010 jan; 9(1):8-14.
  29. Tze Fang ,W et al. Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition. Gynecologic Oncology. 2011 jul; 122(1):141-8. 
  30. Lu JJ, Cai YJ, Ding J. Curcumin induces DNA damage and caffeine-insensitive cell cycle arrest in colorectal carcinoma HCT116 cell. Mol all Biochem. 2011 Aug;354(1-2):247-52.
  31. Darvesh AS, Aggarwal BB, Bishayee A. Curcumin and Liver Cancer: A Review. Curr Pharm Biotechnol. 2012jan;13(1):218-28.
  32. Prakobwong S, et al. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cell through modulatin of multiple cell signaling pathways. Carcinogenesis. 2011 Sep; 32(9):1372-80.
  33. Chen QY, et al. Expression analysis of Cdc42 in lung cancer and modulation of its expression by curcumin in lung cancer cell lines. Int] Oncol. 2012 May;40(5):1561-8
  34. Bistht S, et al. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther. 2010 Aug;9 (8)22255-64.
  35. Ali S, et al. Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells. Cancer Lett. 2012 Jun 28;319(2):173-81.
  36. Teiten MH, et al. Anti-proliferative potential of curcumin in androgen-depen- dent prostate cancer cells occurs through modulation of the Wingless signaling pathway. Int J Oncol. 2011 Mar;38(3):603-11.
  37. Prakobwong S, et al. Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cell through modulatin of multiple cell signaling path- ways. Carcinogenesis. 2011’ Sep;32(9):1372-80.
  38. Ye F, Zhang GH, Guan BX, Xu XC. Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin.World] Gastroen- terol. 2012jan 14; 18(2):126-35.
  39. Dikmen M, Canturk Z, Ozturk Y, Tunali Y. Investigation of the apoptotic effect of curcumin in human leukemia HL-60 cells by using flow cytometry. Cancer Biother Radiopharm. 2010 Dec;25(6):749~55.
  40. Wilken R, Veena MS, Wang MB, Srivatsan ES. Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer. 2011 Feb 7; 10:12.
  41. Mazzarino L, et al. Curcumin-loaded lipid and polymeric nanocapsules stabilized by nonionic surfactants: an in vitro and in vivo antitumor activity on B 16-F10 melanoma and macrophage uptake comparative study. J. Biomed Nanotechnol. 2011 jun;7(3):406-14.
  42. Ma D, Tremblay ,P Mahngar K, CollinsJ, Hudlicky T, Pandey SL. Selective Cytotoxicity against Human Osteosarcoma Cells by a Novel Synthetic C-1 Analogue of 7-Deoxypancratistatin Is Potentiated by Curcumin. PLoS One. 2011;6(12): e28780.
  43. Basnet ,P Skalko-Basnet N. Curcumin: an anti-inflammatory molecule from a curry Spice on the path to cancer treatment. Molecules. 2011 jun 3;16(6):4567-98.
  44. Hossain DS, Bhattacharyya 5, Das T, Sa G. Curcumin: The multi-targeted therapy for cancer regression. Front Biosci (Schol Ed). 2012 Jan 1;4.33.5-55.
  45. Gupta SC, Patchva S, Koh ,W Aggarwal BB. Discovery of Curcumin, a Component of the Golden Spice, and Its Miraculous Biological Activities. Clin Exp Pharmacol Physiol. 2012 Mar;39(3):283-99
  46. Manikandan R, et al. Synergistic anticancer activity of curcumin and catechin: An in vitro study using human cancer cell lines. Res Tech.2012 Feb;75(2): 112-6.
  47. Shanmugam MK, Kannaivan R, Sethi Q. Targeting cell signaling and apoptotic pathways by dietary agent: role in the prevention and treatment of cancer. Nutr Cancer. 2011;63(2):161-73.
  48. Yallapu MM, Gupta BK. Jaggi M, Chauhan SC. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci. 2010 Nov l;351(1):19-29.
  49. Shoba G, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998 May; 64(4): 353-8.
  50. Suresh D, Srinivasan K. Tissue distribution Sr elimination of capsaicin, piperine & curcumin following oral intake in rats. Indian J Med Res. 2010 May;131:682-91.
  51. Patrick Holford “Say no to cancer”, ISBN 978-0-7499-5411-6
  52. Dwivedi V, et al. Cytotoxic potential of Indian spices (extracts) against esophageal squamous carcinoma cells. Asian Pac J Cancer Prev. 2011;12(8):2069-73.
  53. J. Ferlay, F. Bray, P. Piesci, D. Parkin, eds. WHO International Agency for Research on Cancer (IARC), IARC Cancer Epidemiology Database. Globocan 2000. Cancer Incidence, mortality and prevalence worldwide (Lyon, France: IARC Press; 2000)
Dr Saskia Kloppenburg Vieth Medical doscotr and holistic and complementary care practitioner

Consultant in General Internal Medicine (GMC reg. number: 7541548) and Specialist in Complementary Cancer Care
MBBS, MRCIM (Spain), MSc Homeopathy, MFHom, Master practitioner in Ericksonian Hypnotherapy and Neurolinguistic Programming, MSc in Nutrition

Integrated medicine Doctor and Holistic Medicine Practitioner


Private Complementary and Alternative Healthcare clinic.
1st Floor
185 Tower Bridge Road
United Kingdom
crossmenu Tap to Call linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram